Sien Zhao

Ningxia Medical University — China

Medicine · Health Sciences

3h-index28citations10works1.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastrointestinal Tumor Research and Treatment(9), Sarcoma Diagnosis and Treatment(3), Gastric Cancer Management and Outcomes(3), Platelet Disorders and Treatments(2), Vascular Malformations and Hemangiomas(2)

Publications10 total

SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation
Scientific Reports·2025· 2 citedOpen Access
RETRACTED: <scp>LncRNA CCAT2</scp> promotes the proliferation and metastasis of colorectal cancer through activation of the <scp>ERK</scp> and Wnt signaling pathways by regulating <scp>GNB2</scp> expression
Cancer Medicine·2024· 3 citedOpen Access
The Regulation of SPRY4 Intronic Transcript 1 (SPRY4-IT1) on KIT Signaling and Imatinib Resistance of Gastrointestinal Stromal Tumor (GIST) Cells
The Indonesian Biomedical Journal·2024Open Access
Entry of ZSWIM4 to the nucleus is crucial for its inhibition of KIT and BMAL1 in gastrointestinal stromal tumors
Cell & Bioscience·2024· 1 citedOpen Access
RAF1 facilitates KIT signaling and serves as a potential treatment target for gastrointestinal stromal tumor
Oncogene·2024· 2 cited
Four and a half LIM domains 2 (FHL2) attenuates tumorigenesis of gastrointestinal stromal tumors (GISTs) by negatively regulating KIT signaling
Molecular Carcinogenesis·2024· 3 cited
DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors
Molecular Carcinogenesis·2023· 8 cited
SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib
Gastric Cancer·2023· 9 citedOpen Access
Farnesyltransferase (FTase) Inhibitors Increase Inhibition of KIT Mutants by Imatinib
Reports of Biochemistry and Molecular Biology·2023Open Access
Farnesyltransferase (FTase) Inhibitors Increase Inhibition of KIT Mutants by Imatinib.
PubMed·2023Open Access

Frequent Co-authors

Shaoting Zhang(9), Liangying Zhang(8), Jinhai Tian(8), Shujing Li(6), Jianmin Sun(6), Anbu Liu(5), Xu Cao(5), Yuanyuan Yu(5), Hui Zhao(5), Zongying Jiang(4), Kun Xiao(3), Ming Wang(3), Zhaoyang Fan(3), Shujing Li(3), Jianmin Sun(3), Liangji Zhou(2), Ru Bai(2), Xu Cao(2), Kun Xiao(2), Zimei Liu(2)